Alamar Biosciences, Inc. (ALMR) Reports Q2 Loss of $0.22

Alamar Biosciences, Inc. (NASDAQ: ALMR) reported Q2 EPS of ($0.22). Revenue for the quarter came in at $29.4 million.

For earnings history and earnings-related data on Alamar Biosciences, Inc. (ALMR) click here.

You May Also Be Interested In

• Warsh: Inflation Data Don’t Suggest Trend Meaningfully Improved
• Yen Weakens To 160 Per Dollar For First Time Since July 31 - Bloomberg
• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak